Wednesday, October 7, 2020 at 8:00 AM
This grand round has already taken place.
October 7th, 2020 1.00 AMA PRA Category 1 Credit Hours 1.00 MOC Points
Description
The Role of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
Dates and Times
Start: 10/7/2020 8:00 AM
End: 10/7/2020 9:00 AM
Objectives
1. Learn the mechanism of action of SGLT-2 inhibitors
2. Learn the therapeutic effect of SGLT-2 inhibitors on the glycemic control in Type 2 diabetes mellitus
3. Learn the renal and cardiovascular effects of SGLT-2 inhibitors
4. Learn the adverse effects of SGLT-2 inhibitors
5. Learn the approach to and practical aspects of SGLT-2 inhibitor therapy
Speakers
Accreditation
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Lori Briody
Department: Medicine
Phone: (631) 444-2065
Email: lori.briody@stonybrookmedicine.edu